undamentalytics Newsletter
Sign in

Docgo Inc. income statement

In fiscal 2025, Docgo Inc. reported revenue of $322m, down 47.7% on the year before, operating income of −$178m (a -55.3% margin) and net income of −$182m, or −$1.84 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue94319441624617322295
Cost of revenue—452524————
Gross profit—−133−83————
Research and development13511121414
Selling and marketing1553212
General and administrative3575103137139133130
Operating income−1515221529−178−183
Interest expense000————
Net interest income−0−112———
Income before tax−1520231628−187−189
Income tax01−8614917
Net income−152435720−182−192
Diluted EPS−$0.25$0.25$0.34$0.06$0.18−$1.84−$1.96
Diluted shares (average)58m95m103m106m109m99m98m
EBITDA−918323145−162−170

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DCGO vs VMDDCGO vs DLHCDCGO vs SBC

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Docgo Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Docgo Inc.